Variable Macro X Domain of SARS-CoV-2 Retains the Ability...

Main
Variable Macro X Domain of SARS-CoV-2...

Variable Macro X Domain of SARS-CoV-2 Retains the Ability to Bind ADP-ribose

David N. Frick, Rajdeep S. Virdi, Nemanja Vuksanovic

0 / 5.0

Наскільки Вам сподобалась ця книга?

Яка якість завантаженого файлу?

Скачайте книгу, щоб оцінити її якість

Яка якість скачаних файлів?

Рік:

2020

Мова:

english

Сторінки:

8

Файл:

PDF, 467 KB

IPFS:

,

english, 2020

Читати Онлайн

Виконується конвертація в

Конвертація в не вдалась

Можливо вас зацікавить

Piyush Gupta — Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag

Jo Seri & Kim Suwon & Kim Dae Yong & Kim Mi-Sun & Shin Dong Hae — Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

wangke — SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

— B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

— Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

Alexzander A. A. Asea;Punit Kaur; — Coronavirus Therapeutics Volume I

Sunil K. Lal — Molecular Biology of the SARS-Coronavirus

Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris — A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity

Andrés Pizzorno, Blandine Padey, Thomas Julien — Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia

Chantal B.F. Vogels, Anderson F. Brito, Anne L. Wyllie — Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays

Xiaoqiang Huang, Robin Pearce, Yang Zhang — Computational Design of Peptides to Block Binding of the SARS-CoV-2 Spike Protein to Human ACE2

Kevin Dick, Kyle K. Biggar, James R. Green — Computational Prediction of the Comprehensive SARS-COV-2 Vs. Human Interactome to Guide the Design of Therapeutics

Matteo Chiara, David S. Horner, Graziano Pesole — Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-Cov-2

Zhe Liu, Huanying Zheng, Runyu Yuan, Mingyue Li — Identification of a common deletion in the spike protein of SARS-CoV-2

Amaka Ubani, Francis Agwom, Nathan Yakubu Shehu — Molecular Docking Analysis Of Some Phytochemicals On Two SARS-CoV-2 Targets

Jacob Kames, David D. Holcomb, Ofer Kimchi, Michael DiCuccio — Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design

Neha Jain, Uma Shankar, Prativa Majee, Amit Kumar — Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes

Leon Fodoulian, Joel Tuberosa, Daniel Rossier — SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium

Qiang Zhang, Huajun Zhang, Kun Huang, Yong Yang — SARS-CoV-2 neutralizing serum antibodies in cats: A serological investigation

Katie M. Campbell, Gabriela Steiner, Daniel K. Wells — Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles

Chek Meng Poh, Guillaume Carissimo, Bei Wang — Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein

Mahmoud Kandeel, Mohammed Al-Nazawi — Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Jingjiao Li, Mingquan Guo, Xiaoxu Tian, Chengrong Liu — Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis

B. Robson — Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus

Jiumeng Sun, Wan-Ting He, Lifang Wang, Alexander Lai — COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi — COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Balachandar Vellingiri, Kaavya Jayaramayya, Mahalaxmi Iyer, Arul Narayanasamy, Vivekanandhan Govindasamy — COVID-19: A promising cure for the global panic

Ali A. Dawood — Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future

Santosh Kumar, Kaining Zhi, Ahona Mukherji, Kelli Gerth — Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19

Maria Romano, Alessia Ruggiero, Flavia Squeglia, Giovanni Maga, Rita Berisio — A Structural View of SARS‐CoV‐2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping

Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo — Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

Jean Kaoru Millet, Gary R. Whittaker — Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells

Administrator — 1611718

Ключові фрази